Article info
Uterine Cancer
Comparative Use of Napsin A and Glypican 3 to Distinguish Endometrial Clear Cell from Serous and Endometrioid Carcinomas
- Address correspondence and reprint requests to Eirwen M. Miller, MD, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Western Pennsylvania Hospital, Allegheny Health Network, 4815 Liberty Ave, Suite GR30, Pittsburgh, PA 15224. E-mail: eirwen.m.miller{at}gmail.com.
Citation
Comparative Use of Napsin A and Glypican 3 to Distinguish Endometrial Clear Cell from Serous and Endometrioid Carcinomas
Publication history
- Received March 26, 2018
- First published September 1, 2018.
Online issue publication
February 26, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2018 by IGCS and ESGO